These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32463481)

  • 1. Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability.
    Flowers SA; Bhat S; Lee JC
    Pharmacotherapy; 2020 Jul; 40(7):704-712. PubMed ID: 32463481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?
    Chen F; Wen Q; Jiang J; Li HL; Tan YF; Li YH; Zeng NK
    J Ethnopharmacol; 2016 Feb; 179():253-64. PubMed ID: 26723469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota metabolizes nabumetone
    Jourova L; Anzenbacher P; Matuskova Z; Vecera R; Strojil J; Kolar M; Nobilis M; Hermanova P; Hudcovic T; Kozakova H; Kverka M; Anzenbacherova E
    Xenobiotica; 2019 Nov; 49(11):1296-1302. PubMed ID: 30794062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human gut microbiota plays a role in the metabolism of drugs.
    Jourova L; Anzenbacher P; Anzenbacherova E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):317-26. PubMed ID: 27485182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of the Gut Microbiome to Drug Disposition, Pharmacokinetic and Pharmacodynamic Variability.
    Tsunoda SM; Gonzales C; Jarmusch AK; Momper JD; Ma JD
    Clin Pharmacokinet; 2021 Aug; 60(8):971-984. PubMed ID: 33959897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Reactions: Breaking Down Xenobiotic-Microbiome Interactions.
    Clarke G; Sandhu KV; Griffin BT; Dinan TG; Cryan JF; Hyland NP
    Pharmacol Rev; 2019 Apr; 71(2):198-224. PubMed ID: 30890566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical Metabolism of Xenobiotics by Gut Microbiota.
    Nakov R; Velikova T
    Curr Drug Metab; 2020; 21(4):260-269. PubMed ID: 32124693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connecting the dots: Targeting the microbiome in drug toxicity.
    Luo Y; Zhou T
    Med Res Rev; 2022 Jan; 42(1):83-111. PubMed ID: 33856076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gut microbiome influences the bioavailability of olanzapine in rats.
    Cussotto S; Walsh J; Golubeva AV; Zhdanov AV; Strain CR; Fouhy F; Stanton C; Dinan TG; Hyland NP; Clarke G; Cryan JF; Griffin BT
    EBioMedicine; 2021 Apr; 66():103307. PubMed ID: 33819741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of Intestinal Microbiota with Medications.
    Liu M; Xu J; Jin Q; Li Y
    Curr Drug Metab; 2023; 24(8):554-567. PubMed ID: 37073652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Gut Microbiota and Drug Metabolism.
    Pant A; Maiti TK; Mahajan D; Das B
    Microb Ecol; 2023 Jul; 86(1):97-111. PubMed ID: 35869999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota modulates drug pharmacokinetics.
    Zhang J; Zhang J; Wang R
    Drug Metab Rev; 2018 Aug; 50(3):357-368. PubMed ID: 30227749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of gut microbiota on drug metabolism and toxicity.
    Li H; He J; Jia W
    Expert Opin Drug Metab Toxicol; 2016; 12(1):31-40. PubMed ID: 26569070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs.
    Feng W; Liu J; Ao H; Yue S; Peng C
    Theranostics; 2020; 10(24):11278-11301. PubMed ID: 33042283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of common pharmaceutical excipients on the gut microbiota.
    Subramaniam S; Kamath S; Ariaee A; Prestidge C; Joyce P
    Expert Opin Drug Deliv; 2023; 20(10):1297-1314. PubMed ID: 37307224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omics for Understanding the Gut-Liver-Microbiome Axis and Precision Medicine.
    Khalsa J; Duffy LC; Riscuta G; Starke-Reed P; Hubbard VS
    Clin Pharmacol Drug Dev; 2017 Mar; 6(2):176-185. PubMed ID: 28263462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability Based on the Gut Microbiota: a New Perspective.
    Zhang F; He F; Li L; Guo L; Zhang B; Yu S; Zhao W
    Microbiol Mol Biol Rev; 2020 May; 84(2):. PubMed ID: 32350027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Gut Microbiota-Mediated Bile Acid Metabolism on the Solubilization Capacity of Bile Salt Micelles and Drug Solubility.
    Enright EF; Joyce SA; Gahan CG; Griffin BT
    Mol Pharm; 2017 Apr; 14(4):1251-1263. PubMed ID: 28186768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs.
    Noh K; Kang YR; Nepal MR; Shakya R; Kang MJ; Kang W; Lee S; Jeong HG; Jeong TC
    Arch Pharm Res; 2017 Dec; 40(12):1345-1355. PubMed ID: 29181640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ellagitannins, Gallotannins and their Metabolites- The Contribution to the Anti-Inflammatory Effect of Food Products and Medicinal Plants.
    Kiss AK; Piwowarski JP
    Curr Med Chem; 2018; 25(37):4946-4967. PubMed ID: 27655073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.